ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Cerminara, S.E.; Cvijetic, I.; Huber, S.; Müller, S.; Kostner, L.; Goessinger, E.V.; Narainsing, J.; Dutilh, G.; Heidemeyer, K.; Yawalkar, N.; Conrad, C.; Plaza, T.; Maul, J.T.; Cozzio, A.; Navarini, A.A.

doi:10.1111/jdv.20400

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Details

Request a copy

Serval ID

serval:BIB_2627DC6163D3

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Journal

Journal of the European Academy of Dermatology and Venereology

Author(s)

Cerminara S.E., Cvijetic I., Huber S., Müller S., Kostner L., Goessinger E.V., Narainsing J., Dutilh G., Heidemeyer K., Yawalkar N., Conrad C., Plaza T., Maul J.T., Cozzio A., Navarini A.A.

ISSN

1468-3083 (Electronic)

ISSN-L

0926-9959

Publication state

In Press

Peer-reviewed

Oui

Language

english

Notes

Publication types: Letter
Publication Status: aheadofprint

DOI

10.1111/jdv.20400

Pubmed

39445679

Web of science

001341011000001

Open Access

Yes

Create date

28/10/2024 15:00

Last modification date

22/11/2024 16:06

Usage data

SERVAL

serveur académique lausannois

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Details